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ABSTRACT

Background: Transgender, nonbinary, and gender-expansive (TGE) people experience pregnancy. Quantitative data about pregnancy intentions and outcomes of TGE people are
needed to identify patterns in pregnancy intentions and outcomes and to inform clinicians
how best to provide gender-affirming and competent pregnancy care.
Aims: We sought to collect data on pregnancy intentions and outcomes among TGE people
assigned female or intersex at birth in the United States.
Methods: Collaboratively with a study-specific community advisory team, we designed a
customizable, online survey to measure sexual and reproductive health experiences among
TGE people. Eligible participants included survey respondents who identified as a man or
within the umbrella of transgender, nonbinary, or gender-expansive identities; were 18 years
or older; able to complete an electronic survey in English; lived in the United States; and
were assigned female or intersex at birth. Participants were recruited through The PRIDE
Study – a national, online, longitudinal cohort study of sexual and gender minority people –
and externally via online social media postings, TGE community e-mail distribution lists, inperson TGE community events, and academic and community conferences. We conducted
descriptive analyses of pregnancy-related outcomes and report frequencies overall and by
racial and ethnic identity, pregnancy intention, or testosterone use.
Results: Out of 1,694 eligible TGE respondents who provided reproductive history data, 210
(12%) had been pregnant. Of these, 115 (55%) had one prior pregnancy, 47 (22%) had two
prior pregnancies, and 48 (23%) had three or more prior pregnancies. Of the 433 pregnancies, 169 (39%) resulted in live birth, 142 (33%) miscarried, 92 (21%) ended in abortion, two
(0.5%) ended in stillbirth, two (0.5%) had an ectopic pregnancy, and seven (2%) were still
pregnant; nineteen pregnancies (4%) had an unknown outcome. Among live births, 39
(23%) were delivered via cesarean section. Across all pregnancies, 233 (54%) were unintended. Fifteen pregnancies occurred after initiation of testosterone, and four pregnancies
occurred while taking testosterone. Among all participants, 186 (11%) wanted a future pregnancy, and 275 (16%) were unsure; 182 (11%) felt “at risk” for an unintended pregnancy.
Discussion: TGE people in the United States plan for pregnancy, experience pregnancy
(intended and unintended) and all pregnancy outcomes, and are engaged in family building. Sexual and reproductive health clinicians and counselors should avoid assumptions
about pregnancy capacity or intentions based on a patient’s presumed or stated gender or
engagement with gender-affirming hormone therapy.
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Introduction

Transgender, nonbinary, and gender-expansive
(TGE) people (i.e., individuals whose gender
identity differs from the gender identity commonly assumed for the sex assigned to them at
birth) who were assigned female sex at birth
often retain a uterus and may carry pregnancies
(Cipres et al., 2017; Fein et al., 2019; Light et al.,
2018, 2014; Obedin-Maliver & Makadon, 2016).
People assigned intersex at birth or who identify
as intersex are those who have “natural variations
in sex characteristics that do not seem to fit typical binary notions of male or female bodies”
(InterAct Advocates for Intersex Youth &
Lambda Legal, 2018). Such variations do not
necessarily impact capacity for pregnancy,
although some irreversible surgeries completed
on children diagnosed as intersex may impair
fertility (Human Rights Watch & InterAct
Advocates for Intersex Youth, 2017). Despite the
fact that individuals from both of these groups
can and do carry pregnancies, TGE and intersex
people have been excluded from sexual and
reproductive health research. Almost all prior
research has focused on pregnancies solely among
cisgender women (i.e., people whose gender identity aligns with the gender identity commonly
assumed for those assigned female sex at birth)
(Moseson et al., 2020), which presents a narrow
view of reproductive health and family building.
Despite the ability to carry pregnancies, TGE
people assigned female sex at birth face barriers to
accessing high-quality pregnancy-related healthcare, including provider knowledge barriers, structural barriers such as lack of health insurance, and
social barriers such as the fear of discrimination
or misgendering (Hoffkling et al., 2017; James
et al., 2016; Light et al., 2014; Reisner et al., 2010).
Patients, providers, and national professional
organizations, like the American College of
Obstetrics and Gynecology, have called for eliminating these barriers and improving pregnancyrelated resources and care for TGE people
assigned female at birth ( ACOG, 2011; Light
et al., 2014; Obedin-Maliver & Makadon, 2016),
but a dearth of data and resources remain.
Lay press articles and films (Barker, 2018;
Beatie, 2008; Davis, 2001; Finlay, 2019; Hempel,
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2016; Huberdeau, 2012; Pearce & White, 2019),
as well as a growing body of peer-reviewed literature (Beckwith et al., 2017; Ellis et al., 2015;
Hahn et al., 2019; Hoffkling et al., 2017; Light
et al., 2014; 2018; Pearce & White, 2019), have
explored the pregnancy experiences of TGE people. These studies reported the sociodemographic
characteristics of TGE individuals who have been
pregnant, pregnancy intentions, history of gender-affirming hormone use, summary data on
pregnancy outcomes, post-partum care considerations, and qualitative descriptions of the pregnancy experience as a TGE person (Beckwith
et al., 2017; Ellis et al., 2015; Hahn et al., 2019;
Hoffkling et al., 2017; Light et al., 2014; 2018;
Pearce & White, 2019).
As highlighted in the above resources, TGE
individuals encounter a range of unique barriers
to accessing high-quality gynecological and
obstetrical care (Hoffkling et al., 2017; Light
et al., 2014; 2018). Participants in qualitative
research on the pregnancy experiences of TGE
individuals have also reported negotiating tensions between their fertility or family building
intentions and their desire for gender-affirming
hormone therapy, which can be exacerbated by
the lack of research on testosterone use during
pregnancy (Ellis et al., 2015; Hahn et al., 2019;
Hoffkling et al., 2017; Wingo et al., 2018). These
studies serve as resources for clinicians and
healthcare providers and form the basis of the
few clinical recommendations that exist about
pregnancy-related care for TGE people (Dutton
et al., 2008; Makadon et al., 2015; ObedinMaliver & Makadon, 2016).
However, further research with larger study
samples is needed to build the evidence base for
essential reproductive health outcomes including
unintended pregnancies, abortion experiences,
and fertility experiences (Fein et al., 2019; Light
et al., 2018; Obedin-Maliver & Makadon, 2016)
and to inform revisions to existing guidelines.
Generating evidence among larger samples is vital
to gain a more precise understanding of the incidence, prevalence, and patterns of these health
experiences and to inform healthcare provider
education with evidence-based and culturally
competent care for these populations. Toward
this goal, we collected data on pregnancy
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intentions and outcomes among a large sample
of TGE people assigned female or intersex at
birth in the United States.

(LGBTQþ), or as a sexual or gender minority in
the United States (pridestudy.org).
Data collection

Methods
Ethics

This study was reviewed and approved by the
Institutional Review Boards of Stanford
University and the University of California, San
Francisco. In addition, The Population Research
in Identity and Disparities for Equality (PRIDE)
Study Research Advisory Committee and The
PRIDE Study Participant Advisory Committee
(pridestudy.org/pridenet) reviewed and approved
the study. We obtained informed consent from
all survey respondents. The study protocol followed all guidelines and precautions recommended for research involving a vulnerable
population, which for this research included
pregnant persons. The study was designed by a
research team that included TGE individuals and
in close collaboration with a paid, study-specific
community advisory team comprised of five TGE
individuals.
Study design

This study was a self-administered, online, crosssectional survey of sexual and reproductive health
experiences, designed specifically for sexual and
gender minority participants. There were two
enrollment avenues: an online anonymous survey
or through participation in The PRIDE Study. For
the anonymous online survey, eligible participants
included those who were 18-45 years old; were
transgender, nonbinary, or gender-expansive;
assigned female or intersex at birth; resided in the
United States; and could complete an electronic
survey in English. We recruited individuals through
social media posts, outreach to community-based
organizations, e-mail distribution lists, in-person
TGE community events, flyers at academic and
community conferences, and a standalone study
website. Sexual and gender minority individuals
assigned female or intersex at birth and age 18 years
or older could participate through The PRIDE
Study, a longitudinal cohort study of people who
identify as lesbian, gay, bisexual, transgender, queer

We co-created this Qualtrics-based (Qualtrics,
Provo, UT) survey with a community advisory
team as well as The PRIDE Study’s Research and
Participant Advisory Committees. We programmed the survey to allow for customizable
words for sexual and reproductive body parts
and processes to reduce gender dysphoria. We
utilized skip logic to increase question relevance
for individual respondents and to reduce survey
length. Respondents who initiated the survey
were entered into a raffle to win one of 100, $50
electronic gift cards. Survey development, content, and format details are described elsewhere
(Moseson et al., 2020).
The survey focused on core domains related to
gender identity, sexual activity, and sexual and
reproductive health. The primary outcome for
this analysis was gravidity, including a current
pregnancy. Secondary outcomes were: testosterone use in relation to pregnancy, pregnancy
intention, pregnancy outcomes (ongoing pregnancy, miscarriage, ectopic pregnancy, abortion,
stillbirth, live-birth, unknown), and delivery
method. Additional survey questions asked about
future pregnancy intentions, desired timing for
future pregnancy, and whether the respondent
felt “at risk” of unintended pregnancy (defined as
getting pregnant at a time that they did not want
to be pregnant).
Measures

For pregnancy-related outcomes, we developed
an indicator of “ever pregnant” based on whether
a respondent reported “one or more” or zero
pregnancies. Currently pregnant respondents
were classified as “ever pregnant.” The survey
collected detailed information on timing, intention, and outcome of each pregnancy as well as
testosterone use. We classified respondents as
intending to get pregnant in the future, and the
timing of those pregnancy plans, based on
responses to modified Pregnancy Attitudes
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Timing and How (PATH) questions (Callegari
et al., 2017).
We included sociodemographic measures. To
identify which survey respondents met the study
eligibility criteria of being transgender, nonbinary, or gender-expansive, we categorized
respondents based on three questions: (1) an
open-text response question asking respondents
to describe their gender identity, (2) a multiple
choice question asking them to pick all options
that best reflected their gender identity and an
“additional” write-in option if they did not feel
represented by the available options, and (3) a
sex assigned at birth multiple choice question
that included the options “female,” “male,” “not
listed” (with a write-in response), and “prefer not
to say.” We categorized respondents as TGE if
their categorical or free text responses included
any genders other than “cisgender woman” and/
or “woman” (see Table 1 for full list of gender
identity options). We categorized participants as
intersex if they (1) reported an intersex assignment at birth in their open-text response to the
sex assigned at birth question, or (2) if they indicated that they identified as intersex in a subsequent question specific to intersex identity (even
if they reported having been female sex assigned
at birth). To measure race/ethnicity and sexual
orientation, respondents could select all that
apply (including a write-in response) from a list
of ten racial and ethnic identities and a list of ten
sexual orientations.
Analytic approach

We conducted descriptive analyses to closedended survey questions using Stata 15.1
(StataCorp, College Station, TX). We calculated
outcome frequencies overall and by pregnancy
intention status, history of testosterone use, and
racial/ethnic identity category (American Indian
and Alaska Native, Asian, Black or African
American, Hispanic or Latinx, Middle Eastern or
North African, Native Hawaiian and other Pacific
Islander, white, and additionally, a category for
anyone who selected two or more racial identities). We tested for a difference in proportion of
pregnancies reported as unintended between
respondents who reported ever using testosterone
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versus those who reported never using testosterone using a two-tailed test of proportions.
Results
Participant characteristics

Out of 1,694 TGE respondents, approximately
one in four (n ¼ 469, 28%) reported ever using
testosterone (any formulation), and 210 (12%)
reported ever having been pregnant (Table 1).
Among these 210 respondents, median age was
35 years (IQR: 29-42); 56% reported more than
one gender identity [most commonly nonbinary
(52%)]; 99% reported having been assigned
female sex at birth, 0.5% reported being assigned
“both” sexes at birth, and 0.5% reporting being
diagnosed intersex at birth but assigned female;
6% identified as intersex. A minority of everpregnant respondents (28%) identified with a
racial or ethnic identity other than “white,” and
most had health insurance (91%). Over half of
ever-pregnant participants (54%) were parents to
at least one child.
Pregnancy history and use of testosterone

Among the 210 ever-pregnant participants, 115
(55%) had been pregnant a single time, while 95
(45%) had been pregnant 2 to 13 times (Table 2).
Seven (3%) of the ever-pregnant participants
were pregnant at the time of the survey. In the
past twelve months, 16 respondents reported a
pregnancy, or 1% of the sample as a whole
(n ¼ 1,694). To more precisely estimate the pregnancy rate among respondents likely capable of
pregnancy, we excluded respondents who
reported a hysterectomy (n ¼ 175), that they do
not have sex where sperm is released in or near
the vagina (n ¼ 607), and/or were 45 years or
older (n ¼ 107), leaving 16 pregnancies among
955 respondents (1.7%). This translates to an
approximate pregnancy rate of 16.8 pregnancies
per 1,000 TGE respondents with a uterus who
have sex that can lead to pregnancy, per year.
Among respondents who had ever used testosterone, 10% (n ¼ 46) reported ever being pregnant compared to 13% (n ¼ 164) who reported
never using testosterone. Twelve respondents
reported 15 pregnancies that occurred after
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Table 1. Respondent sociodemographic characteristics, overall and by pregnancy history among an online sample of transgender,
nonbinary, and gender-expansive individuals assigned female or intersex at birth in the United States (n ¼ 1,694).
All Respondents
(n ¼ 1,694)

Sample Characteristics
Median age in years, IQR
Age categories
18-19 y
20-24y
25-29y
30-34y
35-39y
40-44y
45-49y
50-54y
55-59y
60-78y
Missing
Gender identities
Agender
Cisgender man
Cisgender woman
Genderqueer
Man
Nonbinary
Transgender man
Transgender woman
Two-spirit
Woman
Additional gender identity
Multiple gender identities
Prefer not to say
Missing
Sex assigned at birth
Female
Not listed
Missing
Identifies as intersex
No
Yes
Prefer not to say
Missing
Sexual orientation
Asexual
Bisexual
Gay
Lesbian
Pansexual
Queer
Questioning
Same-gender loving
Straight/heterosexual
Another sexual orientation
Multiple sexual orientations
Missing
Race/ethnicity
American Indian or Alaska Native
Asian, Central
Asian, East
Asian, South
Asian, Southeast
Black or African American
Hispanic or Latinx
Middle Eastern or North African
Native Hawaiian or Pacific Islander
White
Unknown
Another race
Multiple racial/ethnic identities
None of these
Missing
Education level

Respondents who reported ever having had a pregnancy
(n ¼ 210)

27
n

23-33
%

35
n

29-42
%

150
469
447
284
149
88
38
31
20
18
0

9
28
26
17
9
5
2
2
1
1
0

3
21
38
44
39
28
13
10
5
9
0

1
10
18
21
19
13
6
5
2
4
0

226
1
0
655
293
868
662
4
26
204
197
1036
2
0

13
0
0
39
17
51
39
0
2
12
12
61
0
0

34
1
17
95
19
110
70
1
9
20
24
118
1
0

16
1
8
45
9
52
33
1
4
10
11
56
1
0

1684
10
0

99
0.6
0

208
2
0

99
1
0

1604
69
21
0

95
4
1
0

196
12
2
0

93
6
1
0

252
571
348
218
418
1150
69
111
61
129
1010
21

15
34
21
13
25
68
4
7
4
8
60
1

20
68
47
26
74
142
7
17
4
17
126
0

10
32
22
12
35
68
3
8
2
8
60
0

42
0
41
19
25
67
101
24
5
1472
12
41
202
4
79

3
0
2
1
2
4
6
1
0.3
87
1
2
12
0
5

9
0
4
5
4
8
13
5
0
190
2
7
34
2
5

4
0
2
2
2
4
6
2
0
91
1
3
16
1
2

(continued)
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Table 1. Continued.
Sample Characteristics
High school degree or less
Some college, trade or tech school
College degree
Grad or professional degree
Missing
Health insurance coverage
No
Yes
Don’t know
Missing
US Census Region
Midwest
Northeast
South
West
Missing
Ever pregnant
 Respondents could select all that apply.

All Respondents
(n ¼ 1,694)

Respondents who reported ever having had a pregnancy
(n ¼ 210)

141
410
644
410
89

8
24
38
24
5

13
54
64
71
8

92
1512
10
80

5
89
1
5

12
190
1
7

304
411
326
468
185
210

18
24
19
28
11
12

34
45
44
66
21
210

Table 2. Pregnancy history among an online sample of
transgender, nonbinary, and gender-expansive people assigned
female or intersex at birth in the United States (n ¼ 1,694).
Pregnancy history
Number of pregnancies
0
1
2
3
4
5
6
7
8þ
Missing
Current pregnancy
Yes
Don’t Know
Total number of pregnancies
Number of pregnancies after initiating testosterone
Number of pregnancies while on testosterone

n

%

1455
115
47
17
14
4
5
4
4
29

85.9
6.8
2.8
1
0.8
0.2
0.3
0.2
0.3
1.7

7
1
433
15
4

0.4
0.1
100
3.5
0.9

initiating testosterone (Table 2). Of these 12
respondents, seven (58%) had discussed the
potential interactions between testosterone use
and pregnancy with their health care provider.
Three respondents reported using testosterone at
the time they became pregnant; of these respondents, one reported two pregnancies while using
testosterone. Two of these four pregnancies
ended in miscarriage (one after five months of
testosterone use, one after six months of testosterone use); one ended in abortion (after four
months of testosterone use); and the outcome
and testosterone duration for the fourth pregnancy were not reported. None of the respondents who conceived while using testosterone
remembered if they were still having regular periods at the time they got pregnant. Eight of the 12

6
26
31
34
4
6
91
0.5
3
16
21
21
31
10
100

respondents reported stopping testosterone one
month prior to getting pregnant. Among these,
five stopped testosterone specifically to try to
conceive, and three stopped for unrelated reasons. One respondent did not report if testosterone use was ongoing or only prior to conception.
Pregnancy intention and outcomes

Respondents reported details on pregnancy intention and outcome for 433 pregnancies (Table 3).
Across all 433 pregnancies, the most common
outcome was live birth (n ¼ 169, 39%), followed
by miscarriage (n ¼ 142, 33%) and abortion
(n ¼ 92, 21%). Among live births, 23% (n ¼ 39)
were delivered via cesarean section. Live birth,
abortion, and miscarriage alternated as the most
common pregnancy outcome, depending on
racial and ethnic group (Table 4).
Respondents indicated that they were not trying to get pregnant for 54% of pregnancies
(n ¼ 233) (Table 3). Among unintended pregnancies, abortion was the most common outcome
(n ¼ 88, 38%), followed closely by miscarriage
(n ¼ 86, 37%) and live birth (n ¼ 51, 22%).
Among intended pregnancies, the most common
outcome was live birth (n ¼ 118, 65%) followed
by miscarriage (n ¼ 55, 30%). Intended pregnancies were comparable between respondents who
had ever used testosterone (38%) compared to
those who had not (45%) (p ¼ 0.26). The proportion of ever- pregnant respondents who had
experienced one or more unintended pregnancies
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Table 3. Pregnancy outcomes by intention and use of testosterone, among an online sample of transgender, nonbinary, and
gender-expansive people assigned female or intersex at birth in the United States (n ¼ 1,694).
Outcome of pregnancy

Testosterone use

Were you trying to get Overall Still pregnant Miscarriage Ectopic Abortion Stillbirth Live birth Unknown Ever used Never used Missing
pregnant at this time?
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
n (%)
Yes
183 (42)
7 (4)
55 (30)
0 (0)
2 (1)
1 (0.5)
118 (65)
0 (0)
30 (38)
153 (45)
0 (0)
No
233 (54)
0 (0)
86 (37)
2 (1)
88 (38)
1 (0.4)
51 (22)
5 (26)
49 (62)
184 (54)
0 (0)
Don’t know
5 (1)
0 (0)
1 (20)
0 (0)
2 (40)
0 (0)
0 (0)
2 (11)
0 (0)
5 (1)
0 (0)
Missing
12 (3)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
12 (63)
0 (0)
0 (0)
12 (100)
Total
433 (100)
7 (2)
142 (33)
2 (0.5) 92 (21)
2 (0.5)
169 (39)
19 (4)
79
342
12

was high across all racial and ethnic groups
(Table 4).
Perspectives on future pregnancy

Across all 1,694 TGE respondents, 11% (n ¼ 186)
desired future pregnancy, and an additional 16%
(n ¼ 275) were uncertain (Table 5). Of those who
desired future pregnancy, 16% (n ¼ 29) had previously been pregnant; 12% (n ¼ 34) of those
who were uncertain about future pregnancy
desires had previously been pregnant. Among
those who desired future pregnancy, 17%
(n ¼ 31) would like to get pregnant in the next
year. Nearly one in five respondents considered
themselves to be “at risk” of getting pregnant at a
time when they did not want to be pregnant
(n ¼ 182, 11%) or were unsure about their “risk”
(n ¼ 111, 7%). The proportion who considered
themselves “at risk” for unintended pregnancy
similarly ranged from 9-14% across racial and
ethnic identities, with the exception of one small
group among whom 40% (n ¼ 2) considered
themselves at-risk (Table 4).
Discussion

In this national online survey, 1,694 TGE individuals assigned female or intersex at birth provided
data on pregnancy intentions and outcomes.
More than one in ten participants reported a past
or current pregnancy as well as a desire for
future pregnancy. Respondents provided detailed
information on pregnancy outcomes for 433
pregnancies, testosterone use in relation to pregnancy, and past and future intentions for pregnancy. To our knowledge, this is the largest
report of pregnancies experienced by TGE people. These data offer clinicians, researchers, and
community members a better understanding of

the frequency and distribution of pregnancy outcomes among gender-diverse populations, toward
the goal of improved evidence-based and culturally competent pregnancy care for these
populations.
The frequency of pregnancy outcomes reported
in this study can be compared to only a handful
of prior quantitative studies that report on pregnancy, abortion, birth, miscarriage, and ectopic
pregnancies among TGE individuals in the
United States (Beckwith et al., 2017; Light et al.,
2014; 2018). A 2013 survey reported on the experiences of 41 transgender men who had each
been pregnant and delivered a live neonate (Light
et al., 2014). Among all live births, 30% reported
a cesarean delivery, as compared to 23% reported
in our study, while 32% of pregnancies were
unintended, compared to 54% in ours. We report
fewer pregnancies after initiation of testosterone
(3% versus 61% of pregnancies) but a comparable
percentage of people who reported stopping testosterone to get pregnant (68% versus 73%).
A more recent study reported on 32 transgender men and their 60 pregnancies, 48% of
which resulted in delivery (versus 39% in ours),
23% in miscarriage (versus 33% in ours), 12% in
abortion (versus 21% in ours), and 5% were pregnant at the time of the study (versus 2% in ours)
(Light et al., 2018). A 2018 abstract reported 28
TGE participants with unplanned pregnancy, of
which 36% chose abortion (Beckwith et al.,
2017). We found no difference in likelihood of
intended pregnancy between those who had ever
taken testosterone and those who had not in contrast to a prior study where those who had never
taken testosterone were nearly three times more
likely to have been pregnant than those who had
ever taken testosterone (Light et al., 2018).
With regard to future pregnancy desires, a
small number of prior studies have measured this

N
469
210
1455
115
47
48
29
433
7
142
2
92
2
169
19
39
153
182

Ever use of testosterone

Ever pregnant

Pregnancies per respondent
0
1
2
3þ
Missing

Total pregnancies

Pregnancy outcomes
Still pregnant
Miscarriage
Ectopic pregnancy
Abortion
Stillbirth
Live birth
Unknown
Cesarean birth

Ever had an unintended pregnancy

Considers self at risk for future unplanned pregnancy

11

73
4

8

0
18
0
2
0
14
2
3

36

–
2
33
0.5
21
0.5
39
4
23

33
2
3
4
0

9

N
14

10

89

0
50
0
6
0
39
6
21

–

–
–
–
–
–

21

%
33

American Indian
& Alaska Native
(n ¼ 42)

–
–
–
–
–

12

%
28

Overall
(n ¼ 1694)

9

10

0
9
0
6
0
4
0
1

19

65
9
2
1
0

12

N
15

12

83

0
47
0
32
0
21
0
25

–

–
–
–
–
–

19

%
19

Asian
(n ¼ 77)

6

7

0
5
0
2
0
1
0
0

8

59
8
0
0
0

8

N
18

9

88

0
63
0
25
0
13
0
0

–

–
–
–
–
–

12

%
27

Black or
African American
(n ¼ 67)

14

9

0
4
0
7
0
10
0
1

21

88
7
4
2
0

13

N
26

14

69

0
19
0
33
0
48
0
10

–

–
–
–
–
–

13

%
26

Hispanic or
Latinx
(n ¼ 101)

3

4

0
3
1
1
0
3
0
0

8

19
4
0
1
0

5

N
6

13

80

0
38
13
13
0
38
0
0

–

–
–
–
–
–

21

%
25

Middle Eastern
or North African
(n ¼ 24)

2

0

0
0
0
0
0
0
0
0

0

5
0
0
0
0

0

N
1

40

0

0
0
0
0
0
0
0
0

–

–
–
–
–
–

0

%
20

Native Hawaiian &
other Pacific Islander
(n ¼ 5)

157

139

7
127
2
90
2
158
7
37

393

1280
102
43
45
2

190

N
421

11

73

2
32
0.5
23
0.5
40
2
23

–

–
–
–
–
–

13

%
29

White
(n ¼ 1472)

26

26

1
28
1
15
0
24
0
4

69

168
19
8
7
0

34

N
58

13

76

1
41
1
22
0
35
0
17

–

–
–
–
–
–

17

%
29

Multiple racial
identities
(n ¼ 202)

Table 4. Pregnancy intentions and outcomes by racial and ethnic identities, among an online sample of transgender, nonbinary, and gender-expansive people assigned female or
intersex at birth in the United States (n ¼ 1,694).
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Table 5. Future pregnancy intentions among an online sample of transgender, nonbinary, and gender-expansive people
assigned female or intersex at birth in the United
States (n ¼ 1,694).
Future pregnancy intentions
Would like to get pregnant at some point
No
Yes
Don’t Know
Missing
Would like to get pregnant:
Within next year
Within next 5 years
Within 6-10 years
More than 10 years
Don’t Know

n

%

1030
186
275
203

61
11
16
12

31
60
57
4
11

2
4
3
0
1

sentiment among TGE populations outside of the
United States. One study in Australia found that
13% (n ¼ 21) of 160 transgender and genderdiverse people indicated that they desired to have
children in the future (Riggs et al., 2016) – similar to the 11% reported in our sample. In a study
of 433 transgender people ages 16 years and older
in Canada, 32.3% (n ¼ 148) desired a child in the
future (Pyne et al., 2015). Notably, these two
studies included individuals assigned male at
birth in the study sample – while ours included
only those assigned female or intersex at birth.
Despite these differences, these studies confirm
that many TGE individuals desire future pregnancy, and preconception and pregnancy planning services should be adapted to be more
gender-inclusive and offered to all.
Across studies with quantitative data on pregnancy experiences and outcomes among TGE
individuals, we are beginning to see some patterns. However, due to differences in sample
recruitment, differences in study population by
gender identity and age variation, comparisons
across studies are difficult. Routine collection of
sexual orientation and gender identity information in all administrative datasets that record
pregnancy and birth outcomes will be essential to
understand the baseline epidemiology of these
communities (CDC, 2020).
Implications for practice

These data provide insight into the distribution
of pregnancy experiences and outcomes among
TGE people assigned female or intersex at birth
in the United States. Findings highlight the

reality that TGE people in the United States plan
for pregnancy, experience pregnancy (intended
and unintended) and all pregnancy outcomes,
and are engaged in family building. These results
provide insight into the characteristics of TGE
people who experience pregnancy, and explore
the relationship between pregnancy intentions
and outcomes for this understudied population,
as well as pregnancy outcomes by racial and ethnic identities.
The implications for clinicians are clear: sexual
and reproductive health providers should avoid
assumptions about pregnancy capacity or intentions based on a patient’s presumed or stated
gender or engagement with gender-affirming hormone therapy. The fact that nearly one in five
respondents felt “at risk” of unintended pregnancy, or were unsure of their risk, emphasizes
the need for improved contraceptive counseling
and care delivery for these populations (Agenor
et al., 2020; Bonnington et al., 2020; Boudreau &
Mukerjee, 2019; Krempasky et al., 2020). Toward
the other end of the family planning spectrum,
that one in four respondents desired or were
uncertain about future pregnancy desires underscores the need for providers to evaluate fertility
plans with all patients, regardless of gender, and
to offer high-quality, gender-affirming pre-conception care for those that want it. Relevant for
both those desiring pregnancy and those trying
to avoid pregnancy, the finding that some pregnancies occurred after starting and while using
testosterone reiterates that testosterone does not
completely prevent ovulation or pregnancy even
if it may attenuate it by an unknown amount.
(Bonnington et al., 2020; Krempasky et al., 2020;
Light et al., 2014, 2018). The potential for both
potentially impaired fertility and pregnancy while
using testosterone should be discussed with all
patients initiating testosterone.
The findings presented here add a quantitative
picture to experiences of pregnancy reported so
powerfully by TGE people in the qualitative literature – findings that underscore the need for
quantitative research. TGE people in the United
States have reported delaying pregnancy due to a
lack of data on the influence of testosterone on
pregnancy outcomes, or conversely, delaying gender-affirmation hormone therapy until fertility
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goals are achieved because of this same lack of
data (Hoffkling et al., 2017; Wingo et al., 2018).
It is our hope that the data presented here begin
to address this gap in the evidence.
Limitations

No measures of pregnancy intentions or pregnancy outcomes have been developed or validated
specifically for TGE people. We (in collaboration
with a community advisory team) subsequently
developed our own measures, but we cannot
comment on their sensitivity in capturing the
intended outcomes. Due to the cross-sectional
nature of this survey, these data rely on respondent recall of testosterone initiation and cessation
dates, pregnancy conception dates, and pregnancy
intentions at the time of pregnancy, which may
have occurred many years prior and may be subject to recall bias. Specific to pregnancy intentions, people may be more likely to report a
pregnancy as “intended” when asked retrospectively, even if they were not trying to become
pregnant at that time, because perceptions of past
conception can change over time (Rocca et al.,
2019). As a result, pregnancies reported in this
study as unintended (54%) may be an underestimate. Similarly, even though we asked about
abortion in two different ways, it is well established that people underreport abortion in surveys due to social stigma and a desire to protect
privacy (Jagannathan, 2001; Jones & Forrest,
1992; Moseson et al., 2015). An additional limitation includes the low proportion of respondents
from some racial and ethnic groups: while 28%
of ever-pregnant respondents indicated at least
one race or ethnicity other than “white,” many
groups included only a few respondents. This
limited our ability to evaluate patterns in pregnancy outcomes by racial/ethnic identity.
Finally, although we included participants
assigned both female and intersex at birth in this
analysis, this survey was designed to capture
experiences based on participant gender identity,
not sex assigned at birth. Results of this study do
not offer an in-depth or nuanced analysis of
pregnancy intentions or outcomes that may be
specific to individuals with an intersex assignment at birth or an intersex identity/lived
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experience. These experiences are deserving of
further inquiry.
Conclusion

These findings summarize one of the largest
known datasets of pregnancy intentions and outcomes of TGE people assigned female or intersex
at birth and provide needed insight into the family planning needs of these understudied populations. Clinicians can draw on these data to
inform the information and care provided to
TGE patients related to pregnancy, while TGE
individuals can utilize these findings to contextualize their own reproductive experiences. The
data on the incidence and distribution of major
pregnancy outcomes among TGE people presented here will build the evidence based for gender-inclusive pregnancy care, and can be used to
evaluate where family planning services are succeeding, and where they are falling short, for
TGE people in the United States.
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